IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
about
Multiple sclerosis: the role of cytokines in pathogenesis and in therapiesProtective role of STAT3 in NMDA and glutamate-induced neuronal death: negative regulatory effect of SOCS3Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammationRole of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infectionDifferential requirement for c-Jun N-terminal kinase 1 in lung inflammation and host defenseSOCS3 deficiency promotes M1 macrophage polarization and inflammation.PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation.Expression of suppressor of cytokine signaling-3 (SOCS3) and its role in neuronal death after complete spinal cord injuryCNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia.Astrocytes protect neurons against methylmercury via ATP/P2Y(1) receptor-mediated pathways in astrocytes.Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis.IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses.Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis.Therapeutic potential of AZD1480 for the treatment of human glioblastomaEffects of Reducing Suppressors of Cytokine Signaling-3 (SOCS3) Expression on Dendritic Outgrowth and Demyelination after Spinal Cord Injury.Interaction of astrocytes and T cells in physiological and pathological conditionsIFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.Serum Th1 and Th17 related cytokines and autoantibodies in patients with Posner-Schlossman syndrome.Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD modelA novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.Interleukin-17A Promotes Aortic Endothelial Cell Activation via Transcriptionally and Post-translationally Activating p38 Mitogen-activated Protein Kinase (MAPK) Pathway.IL-17 mediates inflammatory reactions via p38/c-Fos and JNK/c-Jun activation in an AP-1-dependent manner in human nucleus pulposus cellsActivation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells.TLR2/4 deficiency prevents oxygen-induced vascular degeneration and promotes revascularization by downregulating IL-17 in the retina.Astrocytic IL-6 Influences the Clinical Symptoms of EAE in MiceAMP-activated protein kinase restricts IFN-γ signaling.Attenuation of PKR-like ER Kinase (PERK) Signaling Selectively Controls Endoplasmic Reticulum Stress-induced Inflammation Without Compromising Immunological ResponsesNF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastomaModulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanismIL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease.How do immune cells overcome the blood-brain barrier in multiple sclerosis?Interleukin-6, a major cytokine in the central nervous system.Immune players in the CNS: the astrocyte.T Cells-Protective or Pathogenic in Alzheimer's Disease?Gene regulation and genetics in neurochemistry, past to future.Maternal IL-17A in autism.Grape seed proanthocyanidin extract inhibits interleukin-17-induced interleukin-6 production via MAPK pathway in human pulmonary epithelial cells.Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.IL-17-triggered downregulation of miR-497 results in high HIF-1α expression and consequent IL-1β and IL-6 production by astrocytes in EAE mice.
P2860
Q27011014-F25EE5AD-63F9-430C-9379-ED0141E9118CQ28485407-D5064D64-D0AD-4584-8BC1-F4C28B85E919Q28565232-4602166A-B36C-4776-B4AC-007C548EECCBQ34058953-26A7ED79-E181-447B-9E5E-DD939D5C3488Q34238642-5DC623B4-99A3-418C-9881-08DDE20FDCF7Q34287544-3C430628-188F-4452-92A8-C7ABAC078F4FQ34297966-C9D13B14-91BC-45A9-BB29-3F7D24659298Q34325082-9ABE3D4E-6208-4F38-B0B0-D9700203FC8DQ34611991-C45B316C-896C-447A-87D5-819E3AF92876Q34612600-8DEB4E99-840F-48DF-9C5A-C66B8EDC75B2Q35047326-8ADA77D6-3644-4E7A-83B0-FB49CC2D0220Q35134651-C7CB26E0-2E0D-4BE5-9002-B13308C73FE8Q35209789-CEC6E3DA-097B-4D55-AC4C-5E9C4CB4E9F6Q35606563-A0A41F92-98F7-4A07-A24B-63F21AB5CA14Q35613323-E979B7FB-A8DA-48F1-9CB1-DDEADA8AC349Q35780674-D17E5B72-62A3-4DF5-8842-31C6726A5311Q36058899-22CF66BF-8DA3-4310-8330-03A9F13CF7A2Q36086895-67F787C7-A30A-45F7-95CE-C93E38C9828AQ36338274-09F5A547-3B30-4C0B-9680-F7ACE98AE64AQ36428502-0429ADD0-AF1D-44C8-BE36-60F4C7C95533Q36557095-E40646FB-1E71-4F31-A5AA-E851992EDE5CQ36650270-77D6A2E4-6E77-462D-AE06-12AC197663D7Q36694535-CCAE5499-F6ED-4495-9BDD-D99FA23BEBC5Q36852167-B1ED53BA-8226-4015-861E-25595DCA5D13Q37000362-789A8625-CD39-49F7-BADE-5D9AB7F207ACQ37061583-87280901-6D4F-4641-9F3B-CBC1F791DF8CQ37075106-04C3EE9E-12FE-42A6-830F-FB570577A57CQ37117337-4FE5667C-CBC5-44E6-9604-774579170A98Q37297056-42726BF7-8E75-40CD-B9BC-8C885DAC3179Q37574101-57B3B755-2929-4A9A-B712-CD771DF70607Q37865163-754B4345-2478-416E-A6AF-CA11CA13E841Q37873072-DED72DE8-2FC2-4F31-A2AD-13DFC9E655A5Q38058511-F9B07B0B-5936-4B03-BE67-48B308901A81Q38118936-4CFEE4EC-8C9D-4779-98E6-CAC8FC2E77CCQ38469322-F08B3C68-5EF2-4C26-B431-C729522FC0A3Q38802501-F185682A-803F-4BA0-A99B-B044803689D7Q39271108-8C16F374-AEF1-406C-8022-1A8D12A2C51BQ39560205-9A058969-3EC2-4C09-AA8C-3D0CF50F7DBFQ39926107-6BDB4341-6786-4DBE-9D55-9DD52514CC54Q40231889-48F34EA2-C063-4303-B183-033361BB3366
P2860
IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
@en
IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
@nl
type
label
IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
@en
IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
@nl
prefLabel
IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
@en
IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
@nl
P2093
P2860
P356
P1476
IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
@en
P2093
Brandi J Baker
Etty N Benveniste
Hongwei Qin
Stephanie L Reynolds
Xiangyu Ma
Xingang Li
P2860
P304
P356
10.4049/JIMMUNOL.1000142
P407
P577
2010-03-29T00:00:00Z